Nair Anroop B, Dalal Pooja, Kadian Varsha, Kumar Sunil, Garg Minakshi, Rao Rekha, Almuqbil Rashed M, Alnaim Ahmed S, Aldhubiab Bandar, Alqattan Fatemah
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, India.
Plants (Basel). 2023 Mar 3;12(5):1168. doi: 10.3390/plants12051168.
Natural plants and their products continue to be the major source of phytoconstituents in food and therapeutics. Scientific studies have evidenced the benefits of sesame oil and its bioactives in various health conditions. Various bioactives present in it include sesamin, sasamolin, sesaminol, and sesamol; among these, sesamol represents a major constituent. This bioactive is responsible for preventing various diseases including cancer, hepatic disorders, cardiac ailments, and neurological diseases. In the last decade, the application of sesamol in the management of various disorders has attracted the increasing interest of the research community. Owing to its prominent pharmacological activities, such as antioxidant, antiinflammatory, antineoplastic, and antimicrobial, sesamol has been explored for the above-mentioned disorders. However, despite the above-mentioned therapeutic potential, its clinical utility is mainly hindered owing to low solubility, stability, bioavailability, and rapid clearance issues. In this regard, numerous strategies have been explored to surpass these restrictions with the formulation of novel carrier platforms. This review aims to describe the various reports and summarize the different pharmacological activities of sesamol. Furthermore, one part of this review is devoted to formulating strategies to improve sesamol's challenges. To resolve the issues such as the stability, low bioavailability, and high systemic clearance of sesamol, novel carrier systems have been developed to open a new avenue to utilize this bioactive as an efficient first-line treatment for various diseases.
天然植物及其产物仍然是食品和治疗领域中植物成分的主要来源。科学研究已证实芝麻油及其生物活性成分在各种健康状况下的益处。其中存在的各种生物活性成分包括芝麻素、芝麻林素、芝麻酚林和芝麻酚;其中,芝麻酚是主要成分。这种生物活性成分负责预防包括癌症、肝脏疾病、心脏疾病和神经疾病在内的各种疾病。在过去十年中,芝麻酚在各种疾病管理中的应用引起了研究界越来越多的关注。由于其突出的药理活性,如抗氧化、抗炎、抗肿瘤和抗菌作用,芝麻酚已被用于上述疾病的研究。然而,尽管有上述治疗潜力,其临床应用主要受到低溶解度、稳定性、生物利用度和快速清除问题的阻碍。在这方面,人们探索了许多策略,通过构建新型载体平台来克服这些限制。本综述旨在描述各种报道,并总结芝麻酚的不同药理活性。此外,本综述的一部分致力于制定应对芝麻酚挑战的策略。为了解决芝麻酚稳定性差、生物利用度低和全身清除率高这些问题,人们开发了新型载体系统,为将这种生物活性成分用作各种疾病的有效一线治疗开辟了一条新途径。